KPV

KPV is a tripeptide made of lysine, proline, and valine that forms the tail end (residues 11-13) of the hormone alpha-MSH. In cell and animal research it has been investigated for anti-inflammatory effects, particularly in gut and skin models. It is a research chemical, not an approved medicine, and nothing here is medical advice or a recommendation to obtain or use it.

What is KPV?#

KPV is a short peptide whose three-letter name reflects its amino acids: lysine (K), proline (P), and valine (V). The sequence is the carboxy-terminal (C-terminal) fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), a larger hormone involved in pigmentation, energy balance, and immune signaling. Researchers isolated this small fragment to study whether the anti-inflammatory part of alpha-MSH could be separated from its other effects.

Because it is a laboratory research chemical, KPV has not gone through the clinical trials required for a drug to be approved for any medical use. It is usually sold as a lyophilized (freeze-dried) white powder that must be reconstituted with a sterile diluent before it can be measured in liquid form, and it is sometimes labeled "for research use only."

How does KPV work?#

The proposed mechanisms come almost entirely from cell and animal studies, so they should be read as hypotheses rather than established facts. In those models, researchers have reported that KPV may:

• Inhibit NF-kB and MAP kinase signaling, two pathways that drive inflammatory gene activity.
• Lower secretion of pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6.
• Enter cells partly through PepT1, a di/tripeptide transporter expressed in intestinal and immune cells that can increase during gut inflammation.
• Act largely independent of melanocortin receptors, unlike full alpha-MSH, which is one reason it has been studied as a way to keep anti-inflammatory activity while avoiding pigmentation-related effects.

None of these mechanisms has been confirmed in adequately powered human trials. A licensed clinician is the right person to interpret what, if anything, this means for an individual.

What is KPV studied for?#

Most KPV literature is preclinical and centers on inflammation, especially in the gut. The table below summarizes common research themes and their evidence level.

The recurring caveat is the same: animal and cell results do not reliably predict human outcomes, and KPV has not been validated as a treatment for any condition.

Is KPV legal and FDA-approved?#

KPV is not FDA-approved and is not a recognized dietary supplement, so it cannot lawfully be sold for human consumption in the United States. It is marketed only as a research chemical. Its standing under federal pharmacy-compounding rules (the lists that govern which bulk substances compounding pharmacies may use) has been subject to FDA review, but being reviewed or evaluated is not the same as being approved. Regulations differ internationally and can change, so verify current local law and consult a licensed professional before drawing any conclusions about legality.

How is KPV dosed in research?#

There is no validated human dose. Published animal studies use doses and delivery methods (including oral, injected, and nanoparticle-based routes) that do not translate directly to people, and they vary widely between experiments. WikiPeps does not publish dosing protocols. Any decision about quantity, route, or frequency is a medical decision that belongs with a licensed clinician who knows your history.

How is KPV reconstituted?#

Lyophilized KPV is reconstituted by slowly adding bacteriostatic water to the vial and gently swirling until the powder fully dissolves. The numbered steps in the "How To" section above outline the general, education-only process, and our reconstitution guide and mixing-math guide explain how to choose a diluent volume and convert it to syringe units.

What are the safety considerations?#

Human safety data are sparse because rigorous clinical trials have not been completed. Animal studies have generally described KPV as well tolerated, but that does not establish a human safety profile, and absence of evidence is not evidence of safety. The uncertainty is itself a concern: unknown long-term effects, variable product purity and sterility in the research-chemical market, and the absence of regulatory oversight all raise risk. Sterility during handling matters, because contamination can cause infection. Because of these unknowns, the only responsible step before considering any peptide is a conversation with a licensed clinician.

The bottom line#

KPV is a tripeptide fragment of alpha-MSH with promising but almost entirely preclinical anti-inflammatory evidence, concentrated in gut and skin models. It is not FDA-approved, not proven in humans, and is sold only as a research chemical. Treat everything here as education, verify the law where you live, and talk to a licensed clinician before making any health decision.